Emerging Nanomaterials Can Even Treat Chronic Wounds: A Review of Evidence on Magnesium-Based Systems Authors: Yesen Shou, Xuan Zhao, Fan Yang, Xiangjun Bai, Fangli Gao, Zhanfei Li, Yukun Liu, Yuchang Wang Published: 2026 ABSTRACT AbstractChronic wounds remain a severe clinical challenge worldwide due to persistent inflammation, impaired tissue regeneration, and refractory infection control. Recently, magnesium-based materials have garnered tremendous attention for chronic wound healing owing to their exceptional biocompatibility, biodegradability, and multifaceted biological functions in remodeling the wound immune microenvironment. Well-established preclinical evidence demonstrates that magnesium and its derivatives facilitate chronic wound repair by regulating inflammatory responses, promoting angiogenesis, enhancing cellular proliferation and migration, and exerting antibacterial effects, thus constructing a favorable microenvironment for tissue regeneration. Emerging (though still partly speculative) findings suggest that degradation products of magnesium, particularly Mg2⁺ ions, play a central role in directing immune cell polarization, optimizing endothelial cell activity, and alleviating oxidative stress. Magnesium-based inorganic materials, nanostructured systems, and hybrid platforms integrated with hydrogels or other bioactive components also exhibit outstanding preclinical therapeutic potential. It is important to note that the vast majority of current evidence remains at the preclinical stage, and any interpretation of translational readiness should be made with caution. However, the clinical translation of these materials is still severely restricted by multiple bottlenecks: the lack of precise control over magnesium degradation and Mg2⁺ release kinetics, safety risks arising from local pH elevation and hydrogen gas generation, deficient long-term toxicological data, and the absence of standardized evaluation systems for magnesium-based wound dressings. Future research should prioritize the development of tunable and stimuli-responsive delivery systems, deepening mechanistic insights into magnesium-mediated immunomodulation, and incorporating advanced manufacturing technologies to realize personalized therapeutic strategies. Rigorous biosafety evaluations and clinically relevant preclinical models are also imperative. In conclusion, magnesium-based materials stand as a highly promising and versatile strategy for chronic wound repair, holding great potential to be developed as multifunctional platforms that integrate antibacterial, immunoregulatory, and tissue-regenerative properties for clinical translational applications. Introduction Wound healing is a highly coordinated physiological process initiated in response to tissue injury and involves a series of temporally and spatially regulated stages, including inflammation, cellular proliferation and differentiation, extracellular matrix (ECM) deposition, and tissue remodeling.1–3 Under pathological conditions such as diabetes mellitus, peripheral vascular disease, aging, or immune dysfunction, this tightly regulated process can be disrupted. As a result, some wounds become trapped in a vicious cycle characterized by persistent inflammation, oxidative stress imbalance, and impaired regenerative capacity, ultimately progressing into chronic wounds.4–7 Epidemiological studies indicate that the global incidence of chronic wounds continues to rise, particularly among patients with diabetes, in whom approximately 25% are estimated to experience impaired wound healing at some point during their lifetime. Clinically, chronic wounds are associated with prolonged healing times, high recurrence rates, and an increased risk of disability, leading to a substantial decline in patient quality of life and imposing a significant economic burden on healthcare systems worldwide.8–10 Current clinical interventions for chronic wounds mainly include conventional dressings, localized delivery of growth factors, and negative pressure wound therapy. Although these approaches can partially improve the wound microenvironment, they are often limited by insufficient biological activity, unidimensional regulatory mechanisms, and a high susceptibility to secondary infection or excessive scar formation. Consequently, there is an urgent need to develop novel biomaterials that exhibit excellent biocompatibility, actively modulate the wound microenvironment, and effectively promote functional tissue regeneration.11–17 Advances in biomaterials science have opened new avenues for chronic wound management.18 Among various candidate materials, magnesium-based biomaterials have garnered considerable interest due to their unique physicochemical properties and multifaceted biological functions.19–21 Positioned within the broader landscape of metal-based wound biomaterials—such as silver, zinc, and copper—magnesium offers a distinct conceptual advantage:18 it is an essential macroelement in the human body with a well-established safety profile and active participation in metabolic regulation, whereas many other metal ions are primarily used for antimicrobial purposes with less favorable biodegradability and higher long-term toxicity risks.22 Magnesium is an essential macroelement in the human body, participating in more than 300 enzymatic reactions and playing a central role in energy metabolism, calcium–phosphorus homeostasis, and vascular function regulation.23–27 Its density (~1.74 g/cm3) is comparable to that of natural bone, conferring favorable mechanical compatibility that can meet the requirements of soft tissue repair. Moreover, magnesium is fully biodegradable in vivo, and its degradation products are primarily excreted via the kidneys, thereby minimizing the risk of long-term implant-associated complications.28–31 Importantly, the sustained release of magnesium ions (Mg2⁺) during material degradation can activate key signaling pathways, such as PI3K/AKT and MAPK, to promote fibroblast proliferation and migration,32 modulate macrophage polarization and alleviate excessive inflammation,33 enhance endothelial cell proliferation and migration to improve local perfusion, and accelerate fibroblast activation and ECM synthesis.34 In particular, Mg2⁺ has been shown to promote M2 macrophage polarization via regulation of the NF-κB and JAK2/STAT3 signaling pathways, a mechanism that is critical for resolving persistent inflammation and facilitating the transition from the inflammatory phase to the proliferative phase of wound healing.33,35 Collectively, these effects synergistically drive tissue remodeling and closely align with the complex biological demands of chronic wound healing.36–41 With continuous advances in material fabrication technologies, magnesium-based biomaterials have evolved into diverse forms, including magnesium alloys, magnesium-based composites, functional coatings, and micro-/nanostructured drug delivery systems, providing a solid material foundation for their precise application in chronic wound therapy.42–48 Recent studies have further expanded these platforms to include Mg2⁺-loaded carbon quantum dots embedded in electrospun scaffolds for enhanced angiogenesis,34 MgO nanoparticle-functionalized asymmetric aerogels for immune-mediated microenvironment remodeling,49 magnesium–mangiferin self-assembled hydrogels with dual ROS-scavenging and anti-inflammatory capabilities,35 magnesium silicate nanoparticle-integrated microneedle systems with broad-spectrum antibacterial efficacy (sterilization rate >99.9%),32 and magnesium phosphate nanosheet hydrogels that promote antibacterial effects and accelerated wound closure,50 demonstrating the versatility and rapidly expanding scope of magnesium-based platforms for chronic wound management. Despite their promising potential, the clinical translation of magnesium-based biomaterials for chronic wound repair remains challenged by several critical issues, such as mismatches between degradation kinetics and the wound healing timeline, ongoing debates regarding the potential cytotoxicity of high local Mg2⁺ concentrations, and an incomplete understanding of their in vivo mechanisms of action.51–55 Moreover, from a clinical perspective, the unmet endpoints that any new biomaterial must address—including effective infection control, reduction of time to complete closure, and lowering of recurrence rates—remain insufficiently discussed in the material science literature; anchoring the development of magnesium-based systems to these clinical benchmarks will be essential for their successful translation.22 Therefore, this review systematically summarizes the pathophysiological features of chronic wounds and the fundamental properties of magnesium-based biomaterials, with a particular focus on their molecular and cellular mechanisms in immunomodulation, angiogenesis, and tissue remodeling. In addition, we highlight recent advances in fabrication strategies, surface modification approaches, and therapeutic applications of different classes of magnesium-based materials for chronic wound treatment, while critically analyzing existing limitations and outlining future research directions. This work aims to provide both theoretical insights and practical guidance to facilitate the clinical translation of magnesium-based biomaterials and the development of innovative therapeutic strategies for chronic wound management. How Does Chronic Wound Pathophysiology Shape Therapeutic Intervention? The initiation and progression of chronic wounds arise from complex and dynamic interactions among cellular dysfunction, dysregulated molecular signaling, and disruption of microenvironmental homeostasis.56 These multilevel pathological processes form an interconnected network that arrests wound repair at the inflammatory phase, preventing the orderly transition to the proliferative and remodeling stages and thereby establishing a self-sustaining vicious cycle. At the cellular level, functional impairments in multiple reparative cell populations synergistically hinder healing. Fibroblasts, the principal effector cells in wound repair, readily enter a senescent state under chronic inflammatory conditions, exhibiting reduced proliferative and migratory capacity and impaired differentiation into myofibroblasts. Senescent fibroblasts further exacerbate extracellular matrix (ECM) degradation and local inflammation through the secretion of a senescence-associated secretory phenotype (SASP), reinforcing a self-perpetuating pathological loop.57–61 Notably, an imbalance in the number of senescent fibroblasts also compromises repair quality: insufficient fibroblast activity disrupts granulation tissue formation and collagen remodeling, whereas excessive accumulation sustains pro-inflammatory signaling, collectively aggravating repair dysfunction.62–64 Concurrently, keratinocyte migration is markedly impaired in chronic wounds due to multiple converging mechanisms, including excessive ECM degradation that abolishes the structural scaffold required for migration, the formation of bacterial biofilms that act as physical barriers,65,66 the loss of effective chemotactic cues such as growth factors due to degradation or reduced receptor sensitivity,67 and intrinsic cellular senescence driven by persistent inflammation and oxidative stress.68 Recent studies have identified the FOSL1/IL-17 signaling axis as a critical regulator in this process, providing novel mechanistic insights and potential therapeutic targets.69 Impaired angiogenesis represents another hallmark of chronic wounds. Endothelial cells, the central executors of neovascularization, suffer severe functional deterioration in a persistently inflamed milieu.70,71 Overactivated M1 macrophages secrete pro-inflammatory mediators, including TGF-β and IL-6, which disrupt endothelial function via the PI3K/Akt pathway, leading to downregulation or defective internalization of vascular endothelial growth factor receptor-2 (VEGFR2). This, in turn, interferes with Rho GTPase–mediated cytoskeletal remodeling and cell migration, ultimately suppressing new vessel formation.72–75 The resulting tissue hypoxia and impaired nutrient delivery further exacerbate the wound microenvironment, reinforcing a vicious cycle between defective angiogenesis and ischemia. Immune dysregulation also plays a pivotal role in chronic wound pathology. Neutrophils, the first immune cells recruited to injury sites, display persistent and excessive infiltration in chronic wounds, releasing large amounts of matrix metalloproteinases (MMPs) and reactive oxygen species (ROS). These mediators directly degrade ECM structures and inactivate key pro-regenerative growth factors.76–78 Simultaneously, macrophage phenotypic switching is disrupted, preventing efficient transition from the pro-inflammatory M1 phenotype to the reparative M2 phenotype. Coupled with a markedly reduced capacity for efferocytosis, this defect leads to sustained amplification of inflammatory signals and failure of timely resolution, thereby blocking progression from the inflammatory to the proliferative phase.79–81 At the molecular level, persistent inflammation and oxidative stress form a mutually reinforcing pathological loop. M1 macrophages continuously produce pro-inflammatory cytokines such as TNF-α and IL-1β through Toll-like receptor–mediated recognition of damage-associated molecular patterns, while neutrophils generate excessive ROS via NADPH oxidase activation.82–84 These ROS not only inflict direct oxidative damage on biomolecules, resulting in cellular dysfunction, but also activate nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways to upregulate pro-inflammatory gene expression. Concurrently, they suppress the nuclear factor erythroid 2–related factor 2/antioxidant response element (Nrf2-ARE) pathway, a key endogenous antioxidant defense mechanism, thereby establishing a positive feedback loop that perpetuates inflammation and oxidative stress.85–91 Dysregulation of the proteolytic system is another defining feature of chronic wounds. The balance between proteolytic enzymes, such as MMPs and neutrophil elastase abundantly secreted by M1 macrophages and neutrophils, and their endogenous inhibitors is profoundly disturbed, resulting in excessive local proteolytic activity.92–95 Among these enzymes, MMP-8 preferentially degrades newly synthesized collagen fibers, undermining the structural scaffold required for tissue repair, whereas MMP-9 targets basement membrane components and critical reparative factors, including vascular endothelial growth factor, ultimately leading to ECM collapse and interruption of repair-related signaling.96 The consequent reduction in growth factor bioavailability further exacerbates healing impairment. Excessive ECM degradation causes premature release and rapid degradation of matrix-bound growth factors, preventing the establishment of concentration gradients essential for cell migration and proliferation.97 In parallel, persistent inflammation and oxidative stress compromise the function of growth factor–producing cells, driving senescence or apoptosis and resulting in a global decline in growth factor synthesis and secretion.68 In addition, biofilm formation and the chronic wound microenvironment engage in bidirectional reinforcement. Bacteria exploit proteins and polysaccharides in wound exudates to form a conditioning film and progressively develop mature three-dimensional biofilm structures through surface attachment, microcolony formation, and extracellular polymeric substance secretion.98–100 These biofilms not only enhance bacterial resistance to host immune defenses but also exacerbate microenvironmental dysregulation by continuously releasing toxins and sustaining inflammatory activation. In turn, immune imbalance and prolonged exudation create favorable conditions for biofilm persistence, together establishing a stable and deleterious feedback loop.101 Collectively, these interrelated and mutually reinforcing mechanisms constitute the complex pathological network underlying chronic wounds, maintaining the wound microenvironment in a stable yet non-healing state. A comprehensive understanding of the key nodes and dynamic interactions within this system is essential for the development of effective therapeutic strategies for refractory chronic wounds, particularly multifunctional magnesium-based biomaterials capable of targeting multiple pathological processes simultaneously. Synthesis and Fabrication Strategies for Magnesium-Based Biomaterials Traditional metallurgical approaches constitute the foundational manufacturing paradigm for magnesium-based biomaterials. These techniques typically involve multistep processes, including melting under protective atmospheres, plastic deformation, and subsequent heat treatments, through which mechanical performance is markedly enhanced via solid-solution strengthening and grain refinement mechanisms.102,103 Notably, the introduction of powder metallurgy has effectively overcome the intrinsic limitation of conventional cast or wrought magnesium materials, namely the lack of controllable porous architectures.104 By precisely tailoring powder characteristics and sintering parameters—such as particle size, compaction pressure, and sintering temperature—powder metallurgy enables programmable design of pore size and distribution, thereby better accommodating the requirements for permeability and biointegration during wound repair.104,105 Additive manufacturing (AM) technologies represent a paradigm shift in the fabrication of magnesium-based materials, as they enable simultaneous control over macroscopic geometry and microscopic architecture through layer-by-layer digital construction strategies.106 Advanced processes exemplified by selective laser melting allow the fabrication of high-precision scaffolds with graded porosity and fully interconnected three-dimensional pore networks by fine-tuning key parameters such as energy density and scanning pathways. This capability provides a novel solution for achieving a precise balance between degradation kinetics and mechanical performance.107,108 AM techniques can be broadly categorized into seven classes, including material extrusion, material jetting, binder jetting, sheet lamination, powder bed fusion, directed energy deposition, and vat photopolymerization.109 Among these, powder bed fusion and directed energy deposition are the two principal AM routes for metallic components.110,111 Directed energy deposition is primarily suited for producing large, relatively coarse structures, whereas powder bed fusion excels in fabricating complex components with high dimensional accuracy.112 In particular, laser powder bed fusion (LPBF) has demonstrated significant advantages in producing biodegradable magnesium alloy devices featuring internal porous architectures and externally customized geometries.113,114 As a representative AM technique, LPBF can be seamlessly integrated with modern medical imaging modalities, such as computed tomography and magnetic resonance imaging, as well as computer-aided design tools. This integration enables accurate replication of complex anatomical defects and rational design of internal architectures tailored to specific biological functions.113 Despite ongoing technical challenges—including control of magnesium powder reactivity, stabilization of the molten pool, and suppression of internal defects—future efforts are expected to focus on the development of magnesium alloy systems optimized for printability, the establishment of multiphysics-coupled process models, and the exploration of multi-material co-printing strategies to accelerate the clinical translation of personalized magnesium-based implants.106,115 At a more advanced stage of materials design, the fabrication of magnesium-based composites achieves synergistic optimization of structure and function through multiphase system construction and interface engineering. In these systems, magnesium-based units serve as the functional phase and are integrated with biopolymers (such as chitosan and polylactic acid) or bioceramics (including hydroxyapatite and β-tricalcium phosphate) via multiscale fabrication techniques, such as solution casting, electrospinning, and freeze-drying. This approach yields porous scaffolds, fibrous membranes, and hydrogel carriers with precisely defined topological architectures.48,116–120 Through interfacial coupling mechanisms and hierarchical structural design, composite strategies preserve the biological activity of magnesium ions while leveraging the spatial barrier effects of polymer matrices and the grain-boundary stabilization conferred by ceramic phases to achieve programmable control over degradation kinetics.117 More importantly, molecular-level synergy among the constituent phases integrates mechanical compatibility, controlled biodegradability, and biofunctionality within a single platform, thereby establishing a robust theoretical and technical foundation for the development of next-generation intelligent materials for tissue regeneration. Preclinical Applications of Magnesium-Based Biomaterials in Chronic Wound Therapy Chronic wound healing is a multistage process involving inflammation regulation, cellular proliferation, angiogenesis, and tissue remodeling. Conventional wound care materials often show limited clinical efficacy due to poor biocompatibility and single-functionality. In contrast, biodegradable magnesium-based biomaterials have emerged as a research focus for chronic wound treatment because of their anti-inflammatory, pro-angiogenic, and cell-regulatory biological activities, together with their ability to undergo in vivo degradation and metabolism. Through rational material design, magnesium-based systems can be engineered into diverse formulations—such as multifunctional hydrogels, microneedle patches, and nanofibrous dressings—to dynamically adapt to the wound microenvironment and achieve synergistic therapeutic and regenerative outcomes. (Figure 1 and Table 1). Figure 1Schematic illustration of magnesium-based materials used for wound healing. The diagram categorizes various magnesium-based platforms, including: (A) Magnesium-based multifunctional hydrogels, (B) Magnesium-based nanofibrous dressings, and (C) Magnesium-based microneedle systems. These include solid microneedles, hollow microneedles, dissolvable magnesium-based microneedle patches, degradable microneedles, and bioresponsive microneedles. The central circle highlights the role of magnesium (Mg) in the development of these materials, emphasizing their potential in wound healing applications.Diagram of magnesium-based materials for wound healing: hydrogels, nanofibrous dressings, microneedles.The diagram illustrates magnesium-based materials used for wound healing, categorized into three sections. The first section, labeled (A), shows magnesium-based multifunctional hydrogels with various designs, including structures resembling networks and spheres. The second section, labeled (B), depicts magnesium-based nanofibrous dressings, featuring items like a rectangular pad, a porous cube and a dressing with embedded fibers. The third section, labeled (C), presents dissolvable magnesium-based microneedle patches, including solid microneedles, hollow microneedles, degradable microneedles and bioresponsive microneedles. At the center, the role of magnesium (Mg) is highlighted, emphasizing its importance in the development of these materials for wound healing applications. Table 1Summary of Preclinical Applications of Magnesium‑based Biomaterials for Chronic Wound RepairMaterial TypeSpecific Material/CompositionWound ModelKey Mechanism/FunctionMain OutcomesLimitationsRef.Multifunctional hydrogelGTMG hydrogel (gelatin + polydopamine-modified graphene oxide + tannic acid + Mg2⁺)Burn modelModulates macrophage polarization (promotes M2); antibacterial, antioxidant, pro-angiogenicSignificantly accelerates burn wound healingStill at animal experiment stage; long-term biosafety and clinical efficacy need evaluation[121]PDA-PAM/Mg2⁺ hydrogel (polydopamine-polyacrylamide + Mg2⁺)Infected wound model (animal not specified)Photothermal antibacterial (against E. coli and S. aureus); enhances thermal stability; good cytocompatibilityEffectively promotes wound closureFurther validation required for clinical translation; wound model not detailed[122]AA-Mg self-assembled hydrogel (asiatic acid-magnesium, combined with bacterial cellulose)Chronic wound model (animal not specified)Mg2⁺ enhances bioactivity; divalent metal ion-mediated self-assembly; anti-inflammatory, pro-healingFeasibility confirmed for chronic wound managementPreclinical stage; systematic evaluation of long-term safety and efficacy needed[123]Dissolvable microneedle patchMN-MOF-GO-Ag (Mg-based metal-organic framework + graphene oxide + silver, loaded in poly-γ-glutamic acid hydrogel tips)Diabetic wound modelSustained release of Mg2⁺ (promotes cell migration, endothelial tube formation) and gallic acid (ROS scavenger); antibacterialImproves wound microenvironment and accelerates healingPreclinical stage; requires in-depth safety and efficacy validation[124]MN-MgH2 microneedle (PLGA + magnesium hydride)Diabetic wound modelTransdermal release of H2 (reduces oxidative stress) and Mg2⁺ (induces M2 macrophage polarization); promotes cell proliferation, migration, angiogenesisSignificantly enhances tissue regeneration; accelerates refractory wound healingPreclinical stage; promising but needs further validation[41]Nanofibrous dressingJanus electrospun dressing (in situ-doped MgO nanoparticles)Full-thickness skin defect model (animal not specified)Janus structure; inhibits bacterial colonization and growth; regulates collagen deposition and inflammationMarkedly enhances angiogenesis and re-epithelializationResearch lags behind hydrogels and microneedles; needs optimisation and translation efforts[125]PP-MgSi composite nanofibers (PCL-PLLA + MgSiO3)Type 2 diabetic mouse modelControlled release of Mg2⁺ and SiO32−; regulates TNF-α, iNOS, CD206; upregulates CD31 and β3-tubulin; suppresses TNF/IL-17 pathways, activates HIF-1α/VEGF pathwaysDose-dependent acceleration of healing; promotes neurovascular regenerationPreclinical stage; long-term safety and scalability need assessment[126]Magnesium phosphate fibers (PMFs)Full-thickness skin defect modelRegulates macrophage polarization via TRPM7-ERK1/2 pathway; promotes collagen deposition, granulation tissue formation, ECM synthesisSystematically accelerates wound closure; promotes tissue regenerationEarly-stage research; more validation needed for clinical translation[127] Schematic illustration of magnesium-based materials used for wound healing. The diagram categorizes various magnesium-based platforms, including: (A) Magnesium-based multifunctional hydrogels, (B) Magnesium-based nanofibrous dressings, and (C) Magnesium-based microneedle systems. These include solid microneedles, hollow microneedles, dissolvable magnesium-based microneedle patches, degradable microneedles, and bioresponsive microneedles. The central circle highlights the role of magnesium (Mg) in the development of these materials, emphasizing their potential in wound healing applications. Table 1Summary of Preclinical Applications of Magnesium‑based Biomaterials for Chronic Wound RepairMaterial TypeSpecific Material/CompositionWound ModelKey Mechanism/FunctionMain OutcomesLimitationsRef.Multifunctional hydrogelGTMG hydrogel (gelatin + polydopamine-modified graphene oxide + tannic acid + Mg2⁺)Burn modelModulates macrophage polarization (promotes M2); antibacterial, antioxidant, pro-angiogenicSignificantly accelerates burn wound healingStill at animal experiment stage; long-term biosafety and clinical efficacy need evaluation[121]PDA-PAM/Mg2⁺ hydrogel (polydopamine-polyacrylamide + Mg2⁺)Infected wound model (animal not specified)Photothermal antibacterial (against E. coli and S. aureus); enhances thermal stability; good cytocompatibilityEffectively promotes wound closureFurther validation required for clinical translation; wound model not detailed[122]AA-Mg self-assembled hydrogel (asiatic acid-magnesium, combined with bacterial cellulose)Chronic wound model (animal not specified)Mg2⁺ enhances bioactivity; divalent metal ion-mediated self-assembly; anti-inflammatory, pro-healingFeasibility confirmed for chronic wound managementPreclinical stage; systematic evaluation of long-term safety and efficacy needed[123]Dissolvable microneedle patchMN-MOF-GO-Ag (Mg-based metal-organic framework + graphene oxide + silver, loaded in poly-γ-glutamic acid hydrogel tips)Diabetic wound modelSustained release of Mg2⁺ (promotes cell migration, endothelial tube formation) and gallic acid (ROS scavenger); antibacterialImproves wound microenvironment and accelerates healingPreclinical stage; requires in-depth safety and efficacy validation[124]MN-MgH2 microneedle (PLGA + magnesium hydride)Diabetic wound modelTransdermal release of H2 (reduces oxidative stress) and Mg2⁺ (induces M2 macrophage polarization); promotes cell proliferation, migration, angiogenesisSignificantly enhances tissue regeneration; accelerates refractory wound healingPreclinical stage; promising but needs further validation[41]Nanofibrous dressingJanus electrospun dressing (in situ-doped MgO nanoparticles)Full-thickness skin defect model (animal not specified)Janus structure; inhibits bacterial colonization and growth; regulates collagen deposition and inflammationMarkedly enhances angiogenesis and re-epithelializationResearch lags behind hydrogels and microneedles; needs optimisation and translation efforts[125]PP-MgSi composite nanofibers (PCL-PLLA + MgSiO3)Type 2 diabetic mouse modelControlled release of Mg2⁺ and SiO32−; regulates TNF-α, iNOS, CD206; upregulates CD31 and β3-tubulin; suppresses TNF/IL-17 pathways, activates HIF-1α/VEGF pathwaysDose-dependent acceleration of healing; promotes neurovascular regenerationPreclinical stage; long-term safety and scalability need assessment[126]Magnesium phosphate fibers (PMFs)Full-thickness skin defect modelRegulates macrophage polarization via TRPM7-ERK1/2 pathway; promotes collagen deposition, granulation tissue formation, ECM synthesisSystematically accelerates wound closure; promotes tissue regenerationEarly-stage research; more validation needed for clinical translation[127] Summary of Preclinical Applications of Magnesium‑based Biomaterials for Chronic Wound Repair Magnesium-Incorporated Multifunctional Hydrogels for Chronic Wound Repair Multifunctional hydrogels, characterized by their hydrophilic three-dimensional network structures, facilitate oxygen exchange and effectively absorb wound exudates, thereby maintaining an optimal moist environment for healing. Moreover, hydrogels can serve as delivery platforms for cells and bioactive molecules, further accelerating wound repair.128 Despite these advantages, conventional hydrogel dressings often suffer from insufficient degradability, limited functionality, and poor conformity to irregular wound surfaces. To address these limitations, biodegradable magnesium-based multifunctional hydrogels have been developed. The incorporation of magnesium ions (Mg2⁺), which possess both anti-inflammatory and pro-angiogenic properties, significantly enhances the biological activity and therapeutic efficacy of hydrogels.121,123,129 In recent work, Zhao et al developed a gelatin-based multifunctional hydrogel (GTMG) integrating polydopamine-modified graphene oxide (GA), tannic acid (TA), and Mg2⁺.121 In vitro studies demonstrated that GTMG modulates the immune microenvironment—particularly by regulating macrophage polarization—while simultaneously exerting antibacterial, antioxidant, and pro-angiogenic effects, leading to markedly accelerated healing in burn models. This material exhibits strong translational potential as a smart burn dressing. Earlier, Guo et al reported a self-healing and tissue-adhesive PDA-PAM/Mg2⁺ hydrogel,122 in which polydopamine (PDA) imparted pronounced photothermal properties, while Mg2⁺ enhanced thermal stability. The photothermal effect endowed the hydrogel with potent antibacterial activity against Escherichia coli and Staphylococcus aureus. Additionally, the hydrogel showed good cytocompatibility and effectively promoted wound closure, highlighting its potential for clinical adjuvant therapy. In another study, Zhang et al constructed an asiatic acid–magnesium (AA-Mg) self-assembled hydrogel by introducing Mg2⁺, which further enhanced its bioactivity.123 Both in vitro and in vivo experiments confirmed the feasibility of this system for chronic wound management. This divalent metal ion–mediated self-assembly strategy also provides a new avenue for developing functional biomaterials from natural small molecules. Although most magnesium-based multifunctional hydrogels remain at the animal experiment stage, their ability to promote healing, reduce infection, and improve tissue repair quality has been preliminarily validated. These materials hold broad promise for future applications in chronic wound and burn treatment. Nevertheless, their long-term biosafety, clinical efficacy, and scalability for industrial production require further systematic evaluation. Magnesium-Based Dissolvable Polymeric Microneedle Patches for Refractory Wound Treatment Microneedle patches represent an innovative transdermal drug delivery platform that addresses the limited penetration depth and suboptimal efficacy associated with conventional topical therapies. Dissolvable polymeric microneedles enable precise drug loading at the needle tips and rapidly dissolve within the dermis after insertion, releasing encapsulated bioactive agents—including small molecules, proteins, and cytokines—thereby substantially improving delivery efficiency and therapeutic outcomes.130–132 Within this context, Yin et al developed a magnesium-based metal–organic framework microneedle system (MN-MOF-GO-Ag) for combination therapy of diabetic wounds.124 In this design, multifunctional Mg-MOFs were integrated with a poly(γ-glutamic acid) hydrogel and loaded at the microneedle tips. Following insertion, the system continuously released Mg2⁺ and gallic acid into the dermal layer. Mg2⁺ effectively promoted cell migration and endothelial tube formation, while gallic acid acted as a reactive oxygen species scavenger, together improving the wound microenvironment. In another study, Wang et al fabricated a poly(lactic-co-glycolic acid) microneedle patch loaded with magnesium hydride (MN-MgH2) for localized treatment of diabetic wounds (Figure 2).41,121 This system enabled transdermal delivery and sustained release of MgH2, which decomposed in tissue fluid to generate hydrogen gas (H2) and Mg2⁺. The released H2 reduced oxidative stress associated with the diabetic microenvironment, while Mg2⁺ induced macrophage polarization toward the reparative M2 phenotype, collectively enhancing cell proliferation, migration, angiogenesis, and tissue regeneration. By locally and continuously delivering H2 and Mg2⁺, this smart microneedle system offers a novel strategy for accelerating the healing of refractory wounds. Overall, magnesium-based microneedle patches demonstrate substantial potential for chronic wound management. Their multifaceted biological effects may reduce reliance on antibiotics, lower the risk of antimicrobial resistance, and promote tissue regeneration. Although most studies remain at the preclinical stage, these systems exhibit promising prospects for clinical translation, warranting further in-depth validation of their safety and efficacy. Figure 2Schematic illustration of microneedle patch containing MgH2 (denoted as MN-MgH2) and its functional mechanism.41MgH₂ microneedle patch: chemical reactions and biological effects for wound healing.The illustration depicts the mechanism of a microneedle patch containing magnesium hydride (MgH subscript 2) for wound healing. The top section shows the chemical reactions: MgH subscript 2 reacts with water (H subscript 2 O) to form magnesium hydroxide (Mg(OH) subscript 2) and hydrogen gas (H subscript 2). Mg(OH) subscript 2 further reacts with hydrogen ions (H superscript plus) to produce magnesium ions (Mg superscript 2 plus) and water. The lower section illustrates the biological effects of the patch. It reduces reactive oxygen species (ROS) production, promotes M2 macrophage polarization from M0 macrophages, enhances cell proliferation and migration and stimulates angiogenesis. The microneedle patch is shown inserted into the skin, releasing H subscript 2 and Mg superscript 2 plus into the dermal layer, improving the wound microenvironment and promoting healing.Notes: The upward arrows (↑) in the chemical reaction equations are standard chemical notation, universally used to indicate the release of gaseous products (here, hydrogen gas, H2) during chemical reactions. Schematic illustration of microneedle patch containing MgH2 (denoted as MN-MgH2) and its functional mechanism.41 Magnesium-Containing Nanofibrous Dressings for Enhanced Chronic Wound Healing Nanofibrous dressings are typically fabricated via electrospinning, and magnesium-containing nanofiber systems have attracted considerable attention due to their unique physical and biological properties. These fibrous materials possess high surface area and porous architectures, which are favorable for gas exchange and exudate management.126,133 Given the irregular morphology and complex edges of chronic wounds, nanofibrous dressings—with their highly tunable structures and excellent tissue adhesion—can closely conform to wound surfaces and actively participate in the healing process.125 Inspired by the Janus structure and biochemical properties of nano–metal ion systems, Zhou et al developed a Janus electrospun dressing with in situ–doped MgO nanoparticles to address bacterial infection and immune microenvironment imbalance125 (Figure 3). This scaffold not only inhibited bacterial colonization and growth but also modulated collagen deposition and inflammatory responses in full-thickness skin defect models, significantly enhancing angiogenesis and re-epithelialization. Figure 3Schematic illustration of the fabricated electrospinning scaffold inspired by Janus structures and the effect of vascularization and epithelialization to accelerate wound healing (PPGM, PCL/PLLA-Gelatin-MgO electrospun scaffold).125 Becteria should be Bacteria.Electrospinning scaffold for healing: wound environment, anti-bacteria, vascularization, regeneration.The illustration depicts the process of creating an electrospinning scaffold inspired by Janus structures for wound healing. It shows the fabrication of PLLA, gelatin and MgO scaffold applied to a mouse, resulting in a PPGM scaffold. Below, four stages of wound healing are illustrated: wound microenvironment, anti-bacteria and anti-inflammation, vascularization and epidermization and regeneration. Each stage highlights different components such as bacteria, dead bacteria, fibroblasts, inflammatory factors, M1 and M2 macrophages, MgO, endothelial cells, collagen and PCL. The scaffold aims to enhance healing by addressing bacterial infection, promoting angiogenesis and supporting tissue regeneration. Schematic illustration of the fabricated electrospinning scaffold inspired by Janus structures and the effect of vascularization and epithelialization to accelerate wound healing (PPGM, PCL/PLLA-Gelatin-MgO electrospun scaffold).125 Becteria should be Bacteria. In another study, Xu et al constructed a PCL–PLLA–MgSiO3 (PP-MgSi) composite nanofibrous dressing capable of controlled release of Mg2⁺ and SiO32− ions.126 In a type 2 diabetic mouse model, PP-MgSi dressings balanced inflammatory responses by regulating TNF-α, iNOS, and CD206 expression, while upregulating CD31 and β3-tubulin to promote neurovascular regeneration, resulting in dose-dependent acceleration of wound healing. Mechanistic investigations revealed that this material suppressed pro-inflammatory pathways such as TNF and IL-17 signaling, while activating pathways related to neurovascular regeneration, including axon guidance, HIF-1α, and VEGF signaling. Additionally, magnesium phosphate fibers (PMFs), as a novel nanofunctional material, have demonstrated favorable reparative capacity in full-thickness skin defect models.127 PMFs promoted wound closure, collagen deposition, and granulation tissue formation, while sustained Mg2⁺ release modulated the TRPM7–ERK1/2 signaling pathway, thereby directing macrophage polarization, enhancing cell proliferation, growth factor secretion, and ECM synthesis, and ultimately accelerating wound healing in a systematic manner. This material offers new possibilities for open wound management and shows promise in tissue regeneration applications. Despite the multifaceted advantages of magnesium-based nanofibrous dressings in chronic wound management, their research and development currently lag behind those of hydrogels and microneedle systems. Future efforts should focus on further optimization of material systems and advancing studies toward clinical translation. Core Mechanisms Underlying Magnesium-Based Biomaterials for Chronic Wound Healing The diverse biological effects exerted by magnesium-based biomaterials during chronic wound repair do not act in isolation; rather, they form a highly coordinated cascade network. Immunomodulatory actions establish a permissive molecular milieu for angiogenesis, while newly formed vascular networks markedly enhance tissue perfusion, thereby supplying sufficient oxygen and nutrients to support fibroblast activation and function. This cellular activation subsequently drives structural remodeling of the extracellular matrix (ECM). Concurrently, the sustained antibacterial activity and biofilm-inhibitory properties of magnesium-based materials provide critical protection throughout the healing process by effectively preventing microbial infection from disrupting tissue regeneration. Through this multi-targeted, self-reinforcing synergistic mode of action, magnesium-based biomaterials are able to systematically intervene in multiple key pathological stages of chronic wound healing, thereby exhibiting distinct therapeutic advantages (Figure 4). Figure 4Schematic diagram illustrating the multifaceted roles of magnesium (Mg) in wound healing through various biological processes. (A) Immune & Inflammatory Remodeling: Magnesium modulates the polarization of macrophages from the M1 to M2 phenotype, inhibits NF-κB signaling, induces pro-resolving cytokines, and restores immune homeostasis, contributing to reduced inflammation and enhanced tissue repair. (B) Redox Balance & Antimicrobial Defense: Magnesium plays a crucial role in ROS scavenging and maintaining redox homeostasis, activating antioxidant enzymes, establishing a local antimicrobial microenvironment, and destabilizing biofilms to combat infection. (C) Angiogenesis & Microcirculation: Magnesium promotes endothelial cell activation, induces HIF-1α-VEGF signaling, enhances pro-angiogenic factor secretion, and improves microcirculation, fostering blood vessel formation and tissue oxygenation. (D) ECM Remodeling & Tissue Regeneration: Magnesium enhances fibroblast activation and migration, regulates the balance of MMP/TIMP, and supports collagen and ECM deposition, contributing to tissue remodeling and functional tissue regeneration.Magnesium aids wound healing: immune, redox, angiogenesis, ECM regeneration.The diagram illustrates the multifaceted roles of magnesium in wound healing through four quadrants. The center features 'Mg' representing magnesium. In the top left quadrant (A), labeled 'Immune and Inflammatory Remodeling', magnesium modulates macrophage polarization from M1 to M2 phenotype. The top right quadrant (B), 'Redox Balance and Antimicrobial Defense', shows magnesium's role in redox homeostasis and antimicrobial activity. The bottom left quadrant (C), 'Angiogenesis and Microcirculation', depicts magnesium promoting blood vessel formation. The bottom right quadrant (D), 'ECM Remodeling and Tissue Regeneration', highlights magnesium's support in extracellular matrix remodeling and tissue regeneration. Schematic diagram illustrating the multifaceted roles of magnesium (Mg) in wound healing through various biological processes. (A) Immune & Inflammatory Remodeling: Magnesium modulates the polarization of macrophages from the M1 to M2 phenotype, inhibits NF-κB signaling, induces pro-resolving cytokines, and restores immune homeostasis, contributing to reduced inflammation and enhanced tissue repair. (B) Redox Balance & Antimicrobial Defense: Magnesium plays a crucial role in ROS scavenging and maintaining redox homeostasis, activating antioxidant enzymes, establishing a local antimicrobial microenvironment, and destabilizing biofilms to combat infection. (C) Angiogenesis & Microcirculation: Magnesium promotes endothelial cell activation, induces HIF-1α-VEGF signaling, enhances pro-angiogenic factor secretion, and improves microcirculation, fostering blood vessel formation and tissue oxygenation. (D) ECM Remodeling & Tissue Regeneration: Magnesium enhances fibroblast activation and migration, regulates the balance of MMP/TIMP, and supports collagen and ECM deposition, contributing to tissue remodeling and functional tissue regeneration. Immunomodulatory Effects: Reprogramming the Wound Immune Microenvironment Impaired healing of chronic wounds is closely associated with dysregulation of the immune microenvironment, which is characterized by abnormal macrophage polarization, dysfunctional neutrophil activity, persistent oxidative stress, and recurrent microbial infection with biofilm formation. These immune abnormalities are tightly linked to impaired angiogenesis and aberrant collagen deposition, making immunomodulation a central strategy for reversing healing arrest and restoring skin barrier integrity. Magnesium-based biomaterials exert multifaceted immunoregulatory effects primarily through the controlled release of Mg2⁺ ions, influencing the function of various immune cell populations. Mg2⁺ plays a pivotal role in macrophage polarization, a process in which macrophages dynamically transition between the pro-inflammatory M1 phenotype and the anti-inflammatory, pro-regenerative M2 phenotype. Maintaining an appropriate M1/M2 balance is essential for the timely initiation and resolution of wound inflammation.81 Experimental studies have demonstrated that sustained Mg2⁺ release from magnesium nanoflower-loaded hydrogels significantly alters macrophage polarization profiles.134 Flow cytometric analyses revealed a marked reduction in the M1/M2 ratio following Mg2⁺ treatment, indicating a shift toward the M2 phenotype.135 Mechanistically, Mg2⁺ may suppress pro-inflammatory pathways such as NF-κB while simultaneously activating MAPK and PI3K/Akt signaling cascades, collectively promoting M1-to-M2 transition.136,137 Polarized M2 macrophages subsequently secrete anti-inflammatory cytokines (eg., IL-10 and TGF-β) and a variety of growth factors, thereby attenuating chronic inflammation, improving the immune microenvironment, and facilitating downstream tissue repair processes.138 Appropriate Mg2⁺ concentrations are also critical for normal neutrophil recruitment and function.139,140 By promoting M2 macrophage polarization, Mg2⁺ enhances the clearance of apoptotic neutrophils, thereby reducing neutrophil-mediated tissue damage.79,136,137 In adaptive immunity, Mg2⁺ availability has been shown to influence CD8⁺ T cell effector function. Through modulation of innate immune responses and inflammatory signaling, magnesium-based materials can indirectly shape adaptive immunity by suppressing pro-inflammatory Th1 and Th17 responses while promoting regulatory T cell activity, thereby achieving broader immune homeostasis.141–145 Figure 5Schematic Illustrations of (A) Synthesis of Mg-GA MOF, (B) Synthesis of sprayable hydrogel dressing containing Mg-GA MOF, and (C) Mechanism for promoting chronic diabetes wound repair.146Three-part schematic: synthesis of Mg-GA MOF, hydrogel dressing creation and wound repair mechanism.The illustration consists of three parts. The first part shows the synthesis of Mg-GA MOF using gallic acid and magnesium ions through microwave-assisted synthesis, resulting in a functional bio-MOF. The second part depicts the creation of a sprayable hydrogel dressing by combining two components, leading to a product that can kill bacteria. The third part illustrates the mechanism for promoting chronic diabetes wound repair, showing stages of inflammation, proliferation and maturation. It highlights anti-inflammatory actions, cell migration and neurovascular network reconstruction, with a depiction of the hydrogel being applied to a rodent model. Key elements include M1 and M2 macrophages, reactive oxygen species, fibroblasts, endothelial cells and neurons.Notes: The downward arrows (↓) in panel (C) are standard scientific notation, universally used to indicate a decrease or downregulation of the corresponding biological indicators (eg., reduced M1 macrophage polarization, decreased ROS levels) during the wound healing process. The upward arrows (↑) are universally used to indicate a increase or upregulation of the corresponding biological indicators. Schematic Illustrations of (A) Synthesis of Mg-GA MOF, (B) Synthesis of sprayable hydrogel dressing containing Mg-GA MOF, and (C) Mechanism for promoting chronic diabetes wound repair.146 Antioxidative Effects: Mitigating Oxidative Stress in Chronic Wounds A hallmark feature of chronic wounds is persistent oxidative stress, defined by an imbalance between the production and clearance of reactive oxygen species (ROS), which leads to cellular damage and impaired repair capacity. In diabetic wound models, a sprayable hydrogel based on Mg–gallic acid metal–organic frameworks has been shown to alleviate oxidative stress through multiple mechanisms, thereby accelerating wound healing (Figure 5).146 At the molecular level, Mg2⁺ serves as an essential cofactor for key antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx), directly enhancing endogenous antioxidant defenses.23,147 At the cellular level, Mg2⁺ reduces ROS generation by promoting macrophage polarization toward the M2 phenotype, thereby attenuating respiratory burst activity and suppressing NADPH oxidase activation.135,148 At the subcellular level, Mg2⁺ is critical for maintaining mitochondrial stability and metabolic homeostasis, which in turn limits endogenous ROS production.147,149,150 Notably, hydrogen gas (H2) generated during magnesium degradation acts synergistically with Mg2⁺ to form a potent antioxidative system. Dressings capable of controlled H2 release have demonstrated suppression of early inflammation and promotion of re-epithelialization and angiogenesis in murine full-thickness skin defect models.151 Collectively, these multi-tiered antioxidative mechanisms protect reparative cells from oxidative injury, disrupt the vicious cycle between oxidative stress and chronic inflammation, and establish a microenvironment conducive to tissue regeneration.41 Antibacterial Activity and Biofilm Disruption: Defending Against Wound Infection The antibacterial mechanisms of magnesium-based biomaterials have not yet been fully elucidated. Some studies suggest that their antibacterial effects are primarily attributable to localized pH elevation during corrosion rather than direct bactericidal activity of Mg2⁺.152 Robinson et al independently assessed the effects of Mg2⁺ concentration and pH on Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus, demonstrating that bacterial growth inhibition correlated predominantly with increased environmental pH rather than Mg2⁺ levels.153 Consequently, whether magnesium materials can maintain comparable antibacterial efficacy within the complex physiological environment of chronic wounds remains an open question.154 However, a recent recommendation for biological evaluation of biodegradable magnesium-based materials highlights that the coupling impact of pH value and Mg2⁺ concentration together influences antibacterial outcomes. The alkaline condition coupled with increased Mg2⁺ concentrations could produce antibacterial effects against S. aureus and E. coli, while the tolerance of these two bacteria to Mg2⁺ at different pH values was also different.155 Moreover, MgO has been reported to effectively inhibit or kill a broad spectrum of bacteria with minimal safety concerns and no risk of inducing antibiotic resistance.156 Beyond direct antibacterial effects, Mg2⁺ enhances the phagocytic capacity and activity of neutrophils and macrophages.135,157 Thus, even in the absence of direct bactericidal action, Mg2⁺ can augment host immune defenses and improve pathogen recognition and clearance.141 However, Mg2⁺ is also an essential nutrient for bacterial growth, and within certain concentration ranges it may promote the proliferation of specific bacterial species.158 Therefore, the antibacterial role of Mg2⁺ is not binary but context-dependent, modulating bacterial physiology in a manner that mitigates excessive host–pathogen confrontation and favors wound healing. The influence of Mg2⁺ on bacterial adhesion and biofilm formation is both concentration-dependent and species-specific.159 Biofilm stability relies heavily on “ionic bridges” formed by divalent cations between bacterial surfaces and extracellular polymeric substances (EPS).160 Recent studies have demonstrated that optimized anodization parameters on Mg alloys can create nanostructured oxide surfaces that reduce MRSA bacterial adhesion.161 Mg2⁺ exhibits bidirectional effects on biofilm formation: low concentrations may promote biofilm development, whereas high concentrations tend to inhibit it, with responses varying across bacterial species.162 At elevated concentrations, Mg2⁺ can competitively replace Ca2⁺ binding sites within the EPS network via ion-exchange mechanisms. Because Mg2⁺ forms weaker ionic bonds with lower coordination stability, this substitution significantly compromises biofilm structural integrity, converting dense matrices into looser, porous architectures.163 A recent review on Mg alloys in vivo antibacterial properties noted that a major challenge is achieving effective antimicrobial performance alongside controlled corrosion rates. The dual role of antimicrobial additives—which improve antibacterial action but may accelerate corrosion—complicates clinical application.164 Conversely, degradable Mg implants with PCL coatings embedded with host-defense peptides have demonstrated sustained antibacterial efficacy against MRSA for up to 168 h with reduced inflammatory responses.165 This structural disruption yields two critical outcomes: (1) enhanced penetration of antibiotics and immune cells into the biofilm interior, and (2) increased exposure of previously protected bacteria to antimicrobial stress, thereby restoring drug susceptibility.166 Thus, Mg2⁺ acts not as a direct bactericide but as a biofilm-disrupting agent that synergizes with conventional antimicrobial strategies and host immunity. Despite these advantages, magnesium implants have, in some contexts, been reported to exhibit higher susceptibility to bacterial infection compared with conventional materials.167 This underscores the dynamic and complex nature of magnesium–biofilm interactions. Early-stage degradation accompanied by rapid pH elevation and hydrogen release may effectively inhibit initial bacterial adhesion, although this effect can be modulated by physiological buffering systems.168 If early colonization is not fully prevented, subsequent corrosion product deposition may create new adhesion sites, reducing antibacterial efficacy.169 Additionally, nanoscale pores formed during degradation may provide bacterial refuges,170 and once mature biofilms develop, dense EPS matrices further limit sustained antibacterial effects.171 Accordingly, current research efforts focus on controlling magnesium degradation kinetics through surface modification techniques (eg., micro-arc oxidation and polymer coatings) to achieve sustained antimicrobial factor release while preventing premature depletion. Combining magnesium with other antibacterial agents, such as silver, copper, or antibiotics, to construct multi-mechanistic antimicrobial systems is also considered a promising strategy against mature biofilms. For example, ZIF-8@SCC/AgNW nanocone coatings on Mg alloys have achieved antibacterial rates of 99.8% against E. coli and 99.9% against S. aureus under visible light.172 Self-assembled LDHs/silk fibroin multilayer coatings on magnesium alloys have also demonstrated good antimicrobial activity with antibacterial rates reaching 98.71% under NIR irradiation.173 For example, Hu et al developed a dual-network hydrogel incorporating tea polyphenol self-assembled magnesium nanoparticles (TP-Mg NPs) with antibacterial and pro-angiogenic properties (Figure 6).174 In the acidic microenvironment of MRSA-infected wounds, TP-Mg@PSG hydrogels degraded to release TP-Mg NPs, exhibiting potent anti-biofilm activity against MRSA along with excellent biocompatibility, significantly suppressing infection and alleviating inflammation in vivo. Figure 6Schematic illustration of (A) construction of TP-Mg@PSG double network hydrogel, (B) TP-Mg@PSG facilitating healing in MRSA-infected diabetic wounds, and (C) its features of action, reproduced from Ref174 without modification. The mechanism includes two key modes of action: (i) it disrupts bacterial DNA and induces ROS burst to inhibit MRSA, and (ii) TP-Mg releases TP under acidic conditions, promoting enhanced vascularization and regeneration at the wound site. These combined effects contribute to the accelerated healing of diabetic wounds.174Illustration of TP-Mg@PSG hydrogel construction, application in MRSA-infected wounds and its healing mechanisms.The illustration consists of three parts. The first part shows the construction of TP-Mg@PSG hydrogel. Gelatin and sodium alginate are used in 3D printing to create a scaffold, which is then crosslinked and combined with TP-Mg nanoparticles through self-assembly. The second part depicts the application of the composite hydrogel on a wound in a mouse model. The hydrogel is self-adhesive, features double crosslinking and allows controlled drug release. The third part illustrates the hydrogel's mechanisms of action: minimal anti-MRSA concentration, high biocompatibility and wound healing ability. It highlights the roles of tea polyphenol, TP-Mg nanoparticles, MRSA, biofilm, vascularization, fibroblasts, macrophages and endothelial cells in the healing process. Schematic illustration of (A) construction of TP-Mg@PSG double network hydrogel, (B) TP-Mg@PSG facilitating healing in MRSA-infected diabetic wounds, and (C) its features of action, reproduced from Ref174 without modification. The mechanism includes two key modes of action: (i) it disrupts bacterial DNA and induces ROS burst to inhibit MRSA, and (ii) TP-Mg releases TP under acidic conditions, promoting enhanced vascularization and regeneration at the wound site. These combined effects contribute to the accelerated healing of diabetic wounds.174 Pro-Angiogenic Effects: Accelerating Vascular Regeneration in Wounds Magnesium-based biomaterials promote angiogenesis and improve wound microcirculation through the coordinated release of Mg2⁺ ions and hydrogen gas, which collectively regulate endothelial cell function, pro-angiogenic factor expression, and redox balance, thereby accelerating chronic wound healing. Direct Activation of Endothelial Cells In the pathological microenvironment of chronic wounds, endothelial cells often exhibit functional impairment. Mg2⁺ released from magnesium-based biomaterials has been shown to directly regulate endothelial cell behavior via multi-target mechanisms, thereby enhancing vascularization.175 First, Mg2⁺ upregulates key cell cycle regulators such as cyclin D1, facilitating G1/S phase transition and promoting endothelial proliferation.176 Second, Mg2⁺ modulates the expression of magnesium transporters (MagT1) and channels (TRPM7) in a concentration-dependent manner, elevating intracellular Mg2⁺ levels and promoting cytoskeletal reorganization and cadherin expression, which collectively enhance endothelial growth, adhesion, and migration.177 Additionally, as an essential cofactor for DNA polymerases and other nucleic acid metabolic enzymes, Mg2⁺ supports genomic stability and efficient DNA synthesis, providing a molecular foundation for rapid endothelial expansion.178 Regulation of Pro-Angiogenic Factor Networks Magnesium-based biomaterials finely regulate angiogenic factor networks through cascading signaling events. Mg2⁺ released during material degradation activates the PI3K/Akt pathway and enhances HIF-1α transcriptional activity, significantly upregulating vascular endothelial growth factor (VEGF) expression.179 Compared with calcium phosphate silicate (CPS) alone, magnesium-containing CPS markedly increases PI3K, p-PI3K, p-AKT, and VEGF expression.180 Moreover, Mg2⁺-induced macrophage polarization toward the M2 phenotype further expands the angiogenic cytokine repertoire, including VEGF, TGF-β1, and platelet-derived growth factor.181 Notably, Mg2⁺ also increases VEGFR expression density on endothelial cell surfaces, enhancing receptor tyrosine kinase phosphorylation efficiency and signaling sensitivity.182 MgCl2 treatment has been shown to upregulate MMP-2 and MMP-9 expression, facilitating ECM remodeling and endothelial migration.183 ECM remodeling, in turn, enhances VEGF bioavailability and activity.184 Through these multi-level interactions spanning epigenetic regulation, immune microenvironment remodeling, and intracellular signaling, magnesium-based biomaterials effectively correct angiogenic dysregulation in chronic wounds. Improvement of Wound Hemodynamics By promoting the formation and functional maturation of neovascular networks, magnesium-based biomaterials systematically enhance local tissue perfusion and microcirculatory function in chronic wounds. Sustained Mg2⁺ release activates key pathways such as HIF-1α/VEGF, driving endothelial proliferation, migration, and lumen formation to establish dense capillary networks.185 These vascular structures increase vessel density, reduce flow resistance, and elevate tissue oxygen tension and nutrient delivery. Additionally, Mg2⁺ promotes vasodilation by regulating nitric oxide (NO) synthesis pathways, further optimizing local hemodynamic parameters.185 Together, these structural and functional improvements create a hemodynamically favorable environment for tissue regeneration. The Role of Hydrogen Gas Release in Angiogenesis Hydrogen gas (H2) generated during magnesium degradation contributes to angiogenesis through synergistic multi-pathway mechanisms. As a selective antioxidant, H2 efficiently scavenges highly reactive species such as hydroxyl radicals (·OH) and peroxynitrite (ONOO−), alleviating local inflammation and protecting endothelial cells from oxidative injury.186 At the molecular level, H2 promotes angiogenesis by regulating Nrf2-mediated suppression of the Dll4/Notch pathway, inducing Phase II detoxifying enzymes (eg., HO-1 and NQO-1), and modulating the HIF-1α/VEGF axis.187 These coordinated effects on redox homeostasis, signaling pathways, and inflammatory networks establish a systems-level basis for H2-driven neovascularization, offering novel molecular targets for chronic wound therapy. Extracellular Matrix Remodeling and Tissue Regeneration Through Mg2⁺ release, magnesium-based biomaterials regulate protease system balance, promote fibroblast activation and matrix synthesis, and synergize with antibacterial, anti-inflammatory, and microenvironment-optimizing effects to drive orderly ECM deposition and tissue remodeling, ultimately facilitating wound closure188 (Figure 7). Figure 7(A) Schematic diagram of PVA/POA hydrogel network formation. (B) A schematic description of PVA/POA-MX@Mg2+ hydrogel for wound healing.188Two schematics: PVA/POA hydrogel formation and PVA/POA-MX@Mg2+ hydrogel for wound healing.The image A shows a schematic diagram of PVA/POA hydrogel network formation. It illustrates the combination of PVA and POA with MXene and magnesium ions, forming a hydrogel structure. Chemical structures of POA and PVA are depicted, showing their interaction to form the hydrogel. The image B shows a schematic description of PVA/POA-MX@Mg2+ hydrogel for wound healing. It depicts the application of the hydrogel on a wound, highlighting its antibacterial, angiogenesis and wound healing properties. The antibacterial effect is shown with live and dead bacteria. Angiogenesis is indicated by increased CD31 and wound healing is shown with reduced TNF-alpha. The diagram includes a mouse model and labels for NIR, MXene, live bacteria, dead bacteria and vasculum. (A) Schematic diagram of PVA/POA hydrogel network formation. (B) A schematic description of PVA/POA-MX@Mg2+ hydrogel for wound healing.188 Regulation of the Protease System in Wound Remodeling Mg2⁺ precisely modulates ECM metabolism via coordinated molecular mechanisms. As an essential cofactor for matrix metalloproteinases (MMPs), Mg2⁺ enhances the expression and enzymatic activity of MMP-2 and MMP-9.183 Simultaneously, Mg2⁺ regulates the gene expression of tissue inhibitors of metalloproteinases (TIMPs) through specific signaling pathways, preventing excessive protease activation.189 Because the MMP/TIMP ratio directly determines ECM degradation rates, this bidirectional regulation provides a molecular basis for controlled ECM remodeling in chronic wounds.190 Promotion of ECM Synthesis and Deposition Fibroblasts are the principal effector cells responsible for ECM synthesis, and their activation status directly determines matrix production efficiency. Mg2⁺ enhances directional migration and adhesion of fibroblasts and fibrocytes by regulating integrin affinity and expression density, thereby optimizing interactions with ECM proteins.191,192 In a degradable GelMA/Mg/Zn hydrogel developed by Yang et al, Mg2⁺ release upregulated ZIP6 and ZIP10 expression, facilitating Zn2⁺ influx into human skin fibroblasts (HSFs).31 Elevated intracellular Zn2⁺ promoted STAT3 phosphorylation, driving myofibroblast differentiation and accelerating ECM deposition. Consequently, the GelMA/Mg/Zn hydrogel significantly increased the expression of α-SMA, collagen genes (COL1A1 and COL3A1), MMPs (MMP1 and MMP9), growth factors (EGF and FGF2), and fibronectin (FN), thereby enhancing wound healing in rat full-thickness skin defect models.31 Construction of a Pro-Remodeling Wound Microenvironment Magnesium-based biomaterials create a pro-remodeling microenvironment through multiple mechanisms. Their antibacterial activity suppresses microbial proliferation and associated protease secretion, thereby reducing ECM degradation.135,193 By inducing macrophage polarization toward the M2 phenotype, Mg2⁺ lowers pro-inflammatory cytokine levels and limits inflammation-mediated matrix breakdown.138 Meanwhile, sustained Mg2⁺ release enhances angiogenesis and local perfusion, ensuring adequate oxygen and nutrient supply for fibroblast-mediated collagen synthesis.185 Collectively, these integrated effects—from microbial control and inflammation regulation to metabolic support—establish an optimal microenvironment for orderly ECM remodeling and effective chronic wound healing. Current Clinical Translational Challenges for Magnesium-Based Biomaterials Although magnesium and magnesium-based materials have undergone preliminary clinical exploration in tissue engineering, orthopedic implants, and biodegradable metallic devices,194–196 their application in chronic wound repair remains largely confined to laboratory investigations and animal models, with no formal clinical trials reported to date. This gap highlights the substantial translational barriers that persist for magnesium-based materials in cutaneous wound settings (Figure 8). Figure 8Challenges and future perspectives of magnesium-based biomaterials for chronic wound healing. (A) Uncontrolled degradation (rapid corrosion, pH elevation, H2 evolution, unpredictable Mg2⁺ release) and smart material design (controlled degradation, sustained Mg2⁺ release, stimuli-responsive systems). (B) Safety uncertainties (long-term data, systemic Mg2⁺ accumulation, inflammatory risk) and immunoregulatory strategies (macrophage reprogramming, inflammation resolution, immune-material crosstalk). (C) Translational barriers (patient heterogeneity, wound microenvironment variability, large-animal model limitations) and multifunctional integration (antibacterial synergy, pro-angiogenesis, regenerative microenvironment). (D) Regulatory/manufacturing gaps (undefined classification, GMP pipeline shortage, batch inconsistency) and a standardized clinical translation pathway (standardized models, long-term toxicology, scalable manufacturing).Magnesium biomaterials: challenges in degradation, safety, barriers and regulations with solutions.The infographic presents challenges and solutions for magnesium-based biomaterials in four sections. A shows uncontrolled degradation issues like rapid corrosion and unpredictable magnesium release, with smart material design solutions such as controlled degradation and stimuli-responsive systems. B highlights safety uncertainties, including lack of long-term data and inflammatory risks, with immunoregulatory strategies like macrophage reprogramming. C discusses translational barriers such as patient heterogeneity and limited animal models, with multifunctional integration solutions like antibacterial synergy. D addresses regulatory and manufacturing gaps, including undefined classification and batch inconsistency, with a clinical translation pathway featuring standardized models and scalable manufacturing. Challenges and future perspectives of magnesium-based biomaterials for chronic wound healing. (A) Uncontrolled degradation (rapid corrosion, pH elevation, H2 evolution, unpredictable Mg2⁺ release) and smart material design (controlled degradation, sustained Mg2⁺ release, stimuli-responsive systems). (B) Safety uncertainties (long-term data, systemic Mg2⁺ accumulation, inflammatory risk) and immunoregulatory strategies (macrophage reprogramming, inflammation resolution, immune-material crosstalk). (C) Translational barriers (patient heterogeneity, wound microenvironment variability, large-animal model limitations) and multifunctional integration (antibacterial synergy, pro-angiogenesis, regenerative microenvironment). (D) Regulatory/manufacturing gaps (undefined classification, GMP pipeline shortage, batch inconsistency) and a standardized clinical translation pathway (standardized models, long-term toxicology, scalable manufacturing). One major challenge arises from the intrinsic corrosion behavior of magnesium materials. While the associated local microenvironmental changes—such as pH elevation and hydrogen gas generation—pose lower risks in open wounds than in enclosed tissue compartments, the tolerable ranges of these changes in human wounds have not been systematically defined. This lack of quantitative safety data complicates the determination of appropriate dosing, delivery modalities, and material formats for clinical trial design.197 Moreover, patients with chronic wounds frequently present with complex comorbidities, including diabetes, vascular insufficiency, and persistent infection. The pronounced heterogeneity of the wound microenvironment across patient populations leads to substantial interindividual variability in material degradation kinetics and biological responses, thereby complicating trial stratification, inclusion criteria, and endpoint selection.154,198–200 Long-term safety remains another unresolved issue. Most existing in vivo studies are limited to short observation periods, making it difficult to extrapolate long-term effects in humans, such as systemic Mg2⁺ absorption, electrolyte homeostasis disturbances, chronic inflammatory responses, and material-associated metabolic burden.201,202 In addition, the clinical translation of magnesium-based wound dressings, hydrogels, and micro-/nano-carriers critically depends on their physicochemical stability, batch-to-batch consistency, and compatibility with standard sterilization procedures. However, standardized manufacturing and quality control frameworks that meet medical device regulatory requirements are still lacking.125 Regulatory classification also represents a significant bottleneck. As magnesium-based materials possess both intrinsic bioactivity and degradability, their categorization as wound dressings, implantable devices, or combination products can substantially influence approval pathways. The absence of established regulatory precedents further prolongs the translational timeline. At present, there is also a lack of standardized preclinical evaluation criteria specifically tailored to magnesium-based wound materials. These include validated infection models, large-animal models of refractory diabetic wounds, and toxicological assessment pipelines compliant with GMP and GLP standards. Such deficiencies not only delay the initiation of clinical studies but also dampen industrial incentives for product development and commercialization. Consequently, comprehensive multicenter collaborations and the establishment of standardized evaluation systems are essential to bridge current data gaps prior to clinical trial initiation. In summary, while magnesium-based materials hold considerable promise for chronic wound management, successful clinical translation will require advances in material controllability, long-term safety assessment, standardized evaluation frameworks, regulatory clarity, and scalable manufacturing processes.154,197,198,201,202 Interdisciplinary collaboration, patient-specific risk stratification, and robust, reproducible preclinical evidence will be pivotal in advancing these materials toward clinical application. Future Perspectives and Translational Roadmap for Magnesium-Based Biomaterials The application of magnesium-based materials in chronic wound repair is still at an early but rapidly evolving stage. Their multifaceted biological effects—including promotion of angiogenesis, modulation of the immune microenvironment, antibacterial activity, and enhancement of tissue regeneration—position them as promising candidates for next-generation wound healing platforms. A primary focus of future research will be improving material controllability and functional intelligence.203 Rapid degradation and fluctuating Mg2⁺ release profiles in physiological fluids remain unresolved challenges. Strategies that enable precise regulation of degradation behavior and ion release kinetics—such as surface modification, composite sustained-release architectures, or stimulus-responsive systems (eg., pH-, temperature-, or light-responsive designs)—are expected to be central to improving safety and therapeutic consistency.204–206 From a clinical translation perspective, priority should be given to establishing clinically relevant thresholds for acceptable Mg2⁺ release rates and degradation kinetics based on wound type (eg., diabetic ulcer vs. burn wound), as well as developing standardized in vitro-in vivo correlation models to predict material behavior in individual patients.22,207 In parallel, the immunomodulatory properties of magnesium-based materials are gaining increasing attention. Their effects on macrophage polarization, inflammation resolution, and tissue remodeling warrant deeper mechanistic investigation. Integration with immunoengineering, bioinformatics, and single-cell technologies may facilitate the development of “immunoregulatory” magnesium-based materials tailored to the chronic wound microenvironment, enabling a transition from single-function materials to platforms capable of precisely tuning inflammatory states.49,208 The development of multifunctional composite systems represents another important trend.203,209 Synergistic integration of magnesium with photothermal or photodynamic antibacterial strategies, anti-inflammatory agents, growth factors, exosomes, or other bioactive metal ions may enable more effective coordination of infection control, angiogenesis, and tissue regeneration.204,210–212 Advances in 3D printing, micro-/nano-fabrication, and hydrogel engineering further enable the customization of magnesium-based dressings or injectable systems according to wound geometry and pathological features, paving the way for personalized therapeutic approaches.106,121,123,125,129 To accelerate clinical adoption, future studies should prioritize the development of off-the-shelf magnesium-based products that can be stored long-term without special conditions, alongside patient stratification strategies based on wound biomarkers (eg., inflammatory status, infection profile) to match the most suitable magnesium formulation to each patient.45,213 Despite the predominance of small-animal studies at present, systematic efforts are still required to support clinical translation. These include establishing long-term toxicological evaluation systems aligned with wound repair characteristics, standardized manufacturing pipelines, and large-animal models that more closely recapitulate clinical pathophysiology. Specifically, regulatory science initiatives should be pursued to define clear approval pathways for magnesium-based wound dressings and combination products, including harmonized endpoints for safety (eg., systemic Mg2⁺ absorption, local tissue reactions) and efficacy (eg., time to complete wound closure, infection control rate) in clinical trials. Furthermore, cost-effectiveness analyses and scalability assessments for industrial production will be essential to ensure that these advanced materials can be translated into affordable and accessible therapies.22,207 The key to future progress lies in the deep integration of materials science, wound biology, clinical medicine, and engineering technologies into a cohesive interdisciplinary framework. Multi-center, randomized preclinical trials with blinded outcome assessment should be encouraged to generate robust evidence comparable to clinical study standards.207 Overall, magnesium-based materials hold broad prospects in the field of chronic wound healing, with strong potential to bridge the gap between fundamental research and application-oriented therapeutic strategies. As material controllability, safety profiles, and functional integration continue to advance—supported by more rigorous and systematic preclinical studies—this field is poised to yield a new generation of efficient, safe, and customizable wound repair materials, offering innovative solutions for the treatment of chronic, non-healing wounds (Figure 8). Conclusion Magnesium-based materials are emerging as promising platforms for chronic wound repair due to their biodegradability, bioactivity, and ability to modulate inflammation and angiogenesis. Preclinical studies demonstrate antibacterial effects, immune regulation, and promotion of tissue regeneration, highlighting their therapeutic potential. However, clinical translation remains limited by challenges in controlling degradation and Mg2⁺ release, uncertain local safety, limited long-term toxicology data, and lack of standardized evaluation frameworks. From these translational barriers, three key bottlenecks emerge as core lessons for the field: (i) precise control over degradation kinetics and local Mg2⁺ release; (ii) establishment of standardized preclinical evaluation frameworks; and (iii) long-term safety assessment and well-designed clinical trial protocols. Future advances will require interdisciplinary integration of materials science, wound biology, and clinical research, alongside controllable material design, mechanistic studies, and relevant preclinical models. With systematic validation, magnesium-based materials hold promise as innovative strategies for managing refractory chronic wounds.